ArticleCancer investigation2011

A phase I multicenter study of continuous oral administration of lonafarnib (SCH 66336) and intravenous gemcitabine in patients with advanced cancer.

Nan Soon Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.